Our demonstration that GAB1 is a critical mediator of both PI3K and MEK signaling and SHP099 efficacy in HNSCC alerted us to examine more closely the interaction of GAB1 and SHP2 and how EREG may alter this complex. Here, GAB1 is linked to head and neck squamous cell carcinoma.